Literature DB >> 8354916

Campylobacter immunity and quantitative excretion rates in Thai children.

D N Taylor1, D M Perlman, P D Echeverria, U Lexomboon, M J Blaser.   

Abstract

Campylobacter species were isolated from 61 (15%) of 416 Thai children < 5 years old with diarrhea. Although the baseline levels of Campylobacter-specific antibody increased with age, 80.3% of Campylobacter-infected children seroconverted compared with 12.9% of 45 Shigella-infected patients used as controls. The response to acute infection was greatest in the 6- to 12-month-old group. Nonseroconverters had higher initial IgG levels than did seroconverters (P = .001). Quantitative cultures showed a range of 1-8 log10 Campylobacter cfu/g of stool (median, 6.0 log10), and the seroconversion rate was highest in those with the highest Campylobacter excretion. Fecal Campylobacter excretion was inversely related to age (chi 2 for trend, P = .03). These studies indicate that endemic Campylobacter exposure frequently induces seroconversion in young children, whether Campylobacter is isolated as a single pathogen or one of multiple pathogens, and that fecal excretion of the organism is inversely related to the age-related immune response to infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354916     DOI: 10.1093/infdis/168.3.754

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Epidemiological study on contamination of water and diarrheal diseases in a rural community in northeast Thailand.

Authors:  Q M Haque; H Yoshimura; Y Midorikawa; S Nakamura; A Sugiyama; Y Iwade; P Thongkrajai; T Kuyyakanond; P Mairiang; K Pienthaweechai; T Yamauchi
Journal:  Environ Health Prev Med       Date:  1996-04       Impact factor: 3.674

Review 2.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

3.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 4.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

5.  Immune response to and histopathology of Campylobacter jejuni infection in ferrets (Mustela putorius furo).

Authors:  Kevin W Nemelka; Ammon W Brown; Shannon M Wallace; Erika Jones; Ludmila V Asher; Dawn Pattarini; Lisa Applebee; Theron C Gilliland; Patricia Guerry; Shahida Baqar
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

6.  Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice.

Authors:  Shahida Baqar; Lisa A Applebee; Theron C Gilliland; Lanfong H Lee; Chad K Porter; Patricia Guerry
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

7.  Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.

Authors:  M John Albert; Abu Salim Mustafa; Anjum Islam; Shilpa Haridas
Journal:  mBio       Date:  2013-05-07       Impact factor: 7.867

8.  Immune regulation of a chronic bacteria infection and consequences for pathogen transmission.

Authors:  Ashutosh K Pathak; Kathleen E Creppage; Jacob R Werner; Isabella M Cattadori
Journal:  BMC Microbiol       Date:  2010-08-25       Impact factor: 3.605

9.  Development of a comparative genomic fingerprinting assay for rapid and high resolution genotyping of Arcobacter butzleri.

Authors:  Andrew L Webb; Peter Kruczkiewicz; L Brent Selinger; G Douglas Inglis; Eduardo N Taboada
Journal:  BMC Microbiol       Date:  2015-05-07       Impact factor: 3.605

10.  Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005.

Authors:  Ji-Rong Yang; Ho-Sheng Wu; Chuen-Sheue Chiang; Jung-Jung Mu
Journal:  BMC Infect Dis       Date:  2008-10-31       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.